Ligand validation:3VAK

SO4: SULFATE ION

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VAK_SO4_A_403	70%	95%	0.091	0.91	0.24	0.14	-	-	0	0	100%	1
3VAK_SO4_A_405	63%	93%	0.132	0.931	0.31	0.15	-	-	0	0	100%	1
3VAK_SO4_B_407	39%	96%	0.123	0.827	0.22	0.12	-	-	0	0	100%	1
3VAK_SO4_A_404	35%	96%	0.156	0.843	0.25	0.09	-	-	0	0	100%	1
3VAK_SO4_B_405	24%	92%	0.168	0.802	0.25	0.22	-	-	0	0	100%	1
3VAK_SO4_A_406	14%	95%	0.168	0.728	0.25	0.13	-	-	0	0	100%	1
3VAK_SO4_B_406	5%	96%	0.197	0.608	0.27	0.09	-	-	0	0	100%	1
3VAJ_SO4_A_404	94%	98%	0.069	0.973	0.13	0.15	-	-	0	0	100%	1
3VAG_SO4_B_406	81%	91%	0.087	0.942	0.17	0.34	-	-	0	0	100%	1
4TU8_SO4_A_409	79%	98%	0.11	0.962	0.14	0.14	-	-	0	0	100%	1
3VAI_SO4_A_403	76%	87%	0.112	0.954	0.16	0.45	-	-	0	0	100%	1
4TU9_SO4_A_405	75%	97%	0.113	0.95	0.12	0.2	-	-	0	0	100%	1
1U5W_SO4_B_4410	100%	31%	0.014	0.999	1.83	0.85	1	-	0	0	100%	1
2DBQ_SO4_A_601	100%	81%	0.015	0.999	0.69	0.1	-	-	0	0	100%	1
3RIK_SO4_D_502	100%	70%	0.013	0.999	0.55	0.48	-	-	0	0	100%	1
3RIL_SO4_A_501	100%	66%	0.014	0.999	0.49	0.64	-	-	0	0	100%	1
4AY6_SO4_D_1100	100%	93%	0.014	0.998	0.17	0.27	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.